Marathi
|
Hindi
Download App
Epaper
Home
City
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
City
Home
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Nagpur
Chhatrapati Sambhajinagar
Trending Topics :
Lok Sabha Election 2024
Heatwave In India
Mumbai Water Cut
Maharashtra Lok Sabha Election
IPL 2024
Salman Khan
All
News
Photos
Videos
Alok Malik
FOLLOW
Alok malik, Latest News
National :
Glenmark's post-marketing surveillance shows no safety concerns on use of Favipiravir for COVID-19
The Glenmark Pharmaceuticals' post-marketing surveillance (PMS) study has shown no safety concerns with the use of Favipiravir (FabiFlu®[?]) in India for COVID-19 infection. ...
National :
Glenmark's post-marketing surveillance shows no safety concerns on use of Favipiravir for COVID-19
The Glenmark Pharmaceuticals' post-marketing surveillance (PMS) study has shown no safety concerns with the use of Favipiravir (FabiFlu®[?]) in India for COVID-19 infection. ...
Business :
Glenmark releases interim data from PMS Study on Favipiravir (FabiFlu®)
Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced interim data of 503 patients from its Post Marketing Surveillance (PMS) study on Favipiravir in India. ...
Business :
Glenmark launches Ryaltris®-AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India
Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, announced the launch of Ryaltris®-AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India. ...
Business :
Glenmark launches SUTIB (Sunitinib) - priced 96% lower than the innovator brand- Reduces the risk of kidney cancer progression by 58%
Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today launched SUTIB, the generic version of Sunitinib oral capsules to treat kidney cancer in India. ...
Business :
Glenmark commences 1000 patients Post Marketing Surveillance study with COVID-19 who are administered FabiFlu®
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu® to closely monitor the efficacy and safety of the drug in 1000 patients that ...
Previous Page